Delft, Netherlands

Adrianus Pieter Molenaar


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Adrianus Pieter Molenaar

Introduction

Adrianus Pieter Molenaar is a notable inventor based in Delft, Netherlands. He has made significant contributions to the field of medical applications through his innovative work with oxytetracycline solutions. His research focuses on creating stable and effective formulations for both parenteral and peroral administration.

Latest Patents

Molenaar holds a patent for "Stable solutions of oxytetracycline suitable for parenteral and peroral." This invention relates to a clear, stable, aqueous solution of oxytetracycline, consisting of 1% to 5% by weight of oxytetracycline and water, along with polyvinyl pyrrolidone and a magnesium compound. The solution has a pH range of 8.0 to 9.5 and a concentration of polyvinyl pyrrolidone between 2.5% and 7.49%. This formulation is designed to be free from adverse side effects and stable over long periods of storage, making it suitable for medical applications.

Career Highlights

Molenaar is associated with Koninklijke Nederlandsche Gist-en Spiritusfabriek N.V., where he has contributed to advancements in pharmaceutical formulations. His work has been instrumental in improving the stability and efficacy of oxytetracycline solutions, which are widely used in medical treatments.

Collaborations

Molenaar has collaborated with Hubert Antonius Weber, who is now deceased. Their partnership has likely contributed to the development of innovative solutions in the pharmaceutical field.

Conclusion

Adrianus Pieter Molenaar's contributions to the field of medical applications through his patent on stable oxytetracycline solutions highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…